BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22100301)

  • 1. Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study.
    Crockett SD; Lipkus IM; Bright SD; Sampliner RE; Wang KK; Boolchand V; Lutzke LS; Shaheen NJ
    Gastrointest Endosc; 2012 Jan; 75(1):23-31.e2. PubMed ID: 22100301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
    Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
    Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overutilization of endoscopic surveillance in nondysplastic Barrett's: too much of a good thing?
    Klibansky DA; Gordon SR; Gardner TB
    Gastroenterology; 2012 Jun; 142(7):1614-6. PubMed ID: 22537646
    [No Abstract]   [Full Text] [Related]  

  • 5. Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.
    Stier MW; Lodhia N; Jacobs J; Nozicka D; Kavitt R; Siddiqui U; Waxman I; Konda VJ
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus surveillance: When, how often, does it work?
    Katona BW; Falk GW
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program.
    Shaheen NJ; Green B; Medapalli RK; Mitchell KL; Wei JT; Schmitz SM; West LM; Brown A; Noble M; Sultan S; Provenzale D
    Gastroenterology; 2005 Aug; 129(2):429-36. PubMed ID: 16083700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making.
    Hinojosa-Lindsey M; Arney J; Heberlig S; Kramer JR; Street RL; El-Serag HB; Naik AD
    Dis Esophagus; 2013; 26(7):682-9. PubMed ID: 23383987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
    Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
    Gerson LB; Groeneveld PW; Triadafilopoulos G
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative surveillance endoscopy occurs frequently in patients with short-segment non-dysplastic Barrett's esophagus.
    Melson J; Desai V; Greenspan M; Yau S; Abdalla M; Dhanekula R; Mobarhan S; Shapiro D; Losurdo J; Jakate S
    Dis Esophagus; 2015 Oct; 28(7):660-5. PubMed ID: 24943293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus.
    Gupta N; Gaddam S; Wani SB; Bansal A; Rastogi A; Sharma P
    Gastrointest Endosc; 2012 Sep; 76(3):531-8. PubMed ID: 22732877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
    Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
    Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance.
    Gatenby P; Bhattacharjee S; Wall C; Caygill C; Watson A
    World J Gastroenterol; 2016 Dec; 22(48):10592-10600. PubMed ID: 28082811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.